INZIRQO
- Product NDC
- 70954-522
- 11-digit product format
- 709540522
- Labeler code
- 70954
- Product ID
- 70954-522_d6ace9b2-f8fa-42b9-8338-9e2b5519ef6b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydrochlorothiazide
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- NDA219141
- Marketing category
- NDA
- Marketing start
- 2025-01-30
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- INZIRQO
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HYDROCHLOROTHIAZIDE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0J48LPH2TH |
| Rxcui | 2704012, 2704018 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70954-522-10 | INZIRQO | 80 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 80 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70954-522 | INZIRQO (HYDROCHLOROTHIAZIDE) POWDER, FOR SUSPENSION [ANI PHARMACEUTICALS, INC.] | 1 | Current NDC, 1 package rows | 20250206_41aaea48-6c1b-42c8-a96f-5923d49dc934.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70954-522-10 | 70954052210 | 80 mL in 1 BOTTLE (70954-522-10) | 80 ml | 2025-01-30 | No | No | Current |